News You Can Use
Updates and news related to prostate cancer:
PSMA-PET Improves Detection of Metastases in High-Risk Prostate Cancer
Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by conventional imaging.
To Boost Prostate-Cancer Prevention, Doctors Get Into the Game
Virginia Mason Franciscan Health taps Seattle’s sports love by helping eligible patients learn about prostate-cancer screening at sporting events.
How New Findings on Radiotherapy and ADT Inform Prostate Cancer Treatment
Interpreting results in the context of evolving therapies, patient choice, and ongoing trials.
IMPLEMENT Study Reveals Barriers to Treatment Intensification in Metastatic Prostate Cancer
This study was specifically about the barriers and facilitators to first-line treatment intensification in metastatic castration-sensitive prostate cancer.
Talzenna Plus Xtandi May Improve Survival in Metastatic Castration-Resistant Prostate Cancer
Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower death risk with Talzenna plus Xtandi.
Hydroablation Device Shows Promise for Early Prostate Cancer
Clearance of all visible prostate lesions at 6 months in five treated patients.
Highlights of the 31st Annual PCF Scientific Retreat
Advancing prostate cancer science through clinical trials and powerful data
Testosterone Therapy and Prostate Cancer
Risk-benefit and individualized treatment
PSA Bounce
Understanding temporal fluctuations in prostate cancer after external radiotherapy
Testosterone Supplementation After Treatment for Localized Prostate Cancer
Early data has not demonstrated any increased risk of prostate cancer recurrence or progression in men using testosterone replacement therapy after prostate cancer.